FDA Modernization Act of 2021
Summary
FDA Modernization Act of 2021 This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, computer modeling, and other human biology-based test methods.
Bill status
in committee
1 of 4 stages cleared
Introduction
Oct 2021
Committee Review
Floor Vote
President
Introduced Oct 7, 2021
Last action Oct 7, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Oct 7, 2021
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Oct 7, 2021
Introduced
Introduced in Senate
upper
1 primary · 15 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Rand Paul
RRepublican
Co
Alex Padilla
DDemocratic
Co
Angus S. King, Jr.
IIndependent
Co
Ben Ray Luján
DDemocratic
Co
Bernard Sanders
IIndependent
Co
Cory A. Booker
DDemocratic
Co
John Kennedy
RRepublican
Co
Marco Rubio
RRepublican
Co
Mike Braun
RRepublican
Co
Mike Crapo
RRepublican
Co
Mike Lee
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about S 2952
Scope: US
Hi! I can help you understand S 2952. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline